Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I SAD Study of Arfolitixorin in Healthy Volunteers
NCT03203564Phase 1Completed
- Sponsor
- Isofol Medical
- Start
- Jul 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in colorectal cancer (CRC) comparing Modufolin with Placebo (2 arms). Primary endpoint: Change-from-baseline QTcF at 24 hours. Started Jul 2017; status: completed.
02
Drugs
arfolitixorin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03203564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03203564.